论文部分内容阅读
霉酚酸酯 (ＭＭＦ)可选择性抑制人类Ｔ和Ｂ淋巴细胞 ,从而预防同种肾移植术后急性排斥反应。欧洲ＭＭＦ协作研究组进行了本研究 ,以探明服用ＭＭＦ的患者术后三年的移植物和患者存活率以及ＭＭＦ安全性等情况。共搜集了欧洲 2 0个移植中心从1992年 7月至 1993年 8月期间的 491
Mycophenolate mofetil (MMF) can selectively inhibit human T and B lymphocytes and thus prevent acute rejection after allograft renal transplantation. The European MMF Collaborative Study Group conducted this study to investigate graft and patient survival and MMF safety, etc., for three years after MMF in patients taking MMF. A total of 491 European transplant centers from July 1992 to August 1993 were collected